- Das Institut
- Reisen & Impfen
- Alumni & Freunde
The department of infectious disease epidemiology consists of an assembly of international teams spread throughout the world.
Team Hamburg is part of the Bernhard Nocht Insitute for Tropical Medicine and also the headquarters of the department. Its focus is Research & Development as well as Teaching & Capacity Building.
Team Kumasi is based at the Kumasi Centre for Collaborative Research (KCCR), Ghana, as well as at the Agogo Presbyterian Hospital and other hospitals, where most of our clinical studies are conducted.
Team Arusha is located in Arusha, Tanzania, and is mainly working within the East African Community (EAC) to establish a sustainable laboratory infrastructure and response network across East Africa.
Team Tanga is based at the National Institute for Medical Research (NIMR) in Tanga, as well as at the Magunga District Hospital in Korogwe, Tanzania.
Team Antananarivo is based at the University of Antananarivo at the Laboratoire de Microbiologie et de Parasitologie Université Antananarive (LMPUA) in Madagascar and is contributing to our research projects as well.
Team Vientiane is located at the National Insitute Of Public Health (NIOPH) in Vientiane and in Savanaketh, Laos
Team Hué is based at the Hué University of Medicine and Pharmacy (HUMP) in Vietnam
The focus of the Research and Development group is the performance of studies on communicable diseases of humans. The concept includes the planning, preparation, supervision, performance and analysis of observational studies and clinical trials, combining classical, molecular and clinical epidemiology. Focus diseases are malaria, salmonellosis, cryptosporidiosis, sepsis, neglected tropical diseases (NTD) and co-infections in resource-poor settings. The group is interested in the development, evaluation and application of advanced diagnostics of infectious diseases, integration of electronic surveillance, definition of health priorities, and the analysis of the pathogens and their transmission conditions. The latter includes the analysis of genetic, environmental, socio-economic, demographic, and spatio-temporal risk factors on the host site as well as influence factors of the pathogens and vectors. The superior aim is the translation of results to implementation of diagnostics, treatment, prevention and capacity building in endemic countries. The studies are mainly performed together with the Kumasi Center for Collaborative Research (KCCR), the Ghana School of Public Health of the University of Ghana and different hospitals and communities in the Ashanti Region. Other cooperation partners are in many other African countries as well as in Vietnam and Laos. More
Health threats in populations require global and international preparedness and effective responses. The infectious disease epidemiology department of BNITM contributes to this through teaching and capacity-building initiatives in Africa, the Middle East, and Central and South Asia.
These aim to:
The preparation of the research sites in Madagascar for the freeBILy clinical trial entered its last phase. Staff has been recruited and a dedicated training has been coordinated in Ambositra by the BNITM team. Leaders of the partners institutions (University of Antananarivo, University of Fianarantsoa and Centre d’Infectiologie Charles Mérieux) actively contributed to the training activities. A successful clinical trial must involve the communities. The staff must be ready to vehiculate targeted and correct information about the study at any moment. In this view, research nurses, data manager, lab technicians but also the drivers were all trained on the main objectives of the study and on good clinical practices. Simulation exercises have been performed in order to mimic their future routine activities but also to prepare the staff to prompt and efficient reactions in case of non-expected scenarios. freeBILy is a project targeting mothers and child health. Many of the nurses within the staff are mothers and their children already became the mascot of the team! The trial is expected to start in the first months of 2019.
The third and last workshop of the GIBACHT (Global Partnership Initiated Academia for the Control of Health Threats) programme took place in Kampala/Uganda from 15-19 October 2018. Together with our partners from the Robert Koch Institute, the Swiss Tropical and Public Health Institute, and the African Field Epidemiology Network, we spent a week with the 15 fellows from 11 countries to complete their one-year biosafety and biosecurity training. Over the course of the programme, each of the fellows had developed a written case study with relevance for biosafety and biosecurity to be used as a teaching tool. A main focus of the workshop was the pilot testing of the case studies with students invited from the Makerere University of Kampala. Within the next six months, the fellows are going to apply the train-the-trainer concept and implement the case studies at their home institutions.
In January 2019, the department Infectious Disease Epidemiology at the BNITM will launch a new project in both Ghana and Tanzania on "genetic adaptation of non-typhoid Salmonella within human and animal reservoirs in sub-Sahara Africa". This work will be funded by the German Research Foundation (DFG), which supports joint research projects between scientists in Germany and Africa investigating infectious diseases and their social implications.
Within the cooperation between Setthatirath Hospital in Vientiane capital city, Lao PDR and Bernhard Nocht Institute (Klinikpartnerschaften) our team in Vientiane organises workshops about management of snakebites for medical staff in central, provincial and district hospitals. Capacity building is crucial to improve medical care for snakebite victims and to implement solid research thereafter.
After the first workshop of the GIBACHT programme (Global Partnership Initiated Academia for the Control of Health Threats) at the BNITM in April (see below), the fellows met for a second workshop at the Robert Koch Institute (RKI) in Berlin from 16-20 July 2018. With our partners from the RKI, the Swiss Tropical and Public Health Institute, and the African Field Epidemiology Network, we continued the biosafety and biosecurity training with real-time simulations of catastrophic health events. In group work, the fellows had to respond to fictional biological incidents from the perspective of a public health institution. This involved performing risk assessments of the evolving situation, deciding on control and containment measures, incorporating communication with the public, and developing preparedness plans for future incidents. The fellows will meet again during the third/last workshop of this cohort in Kampala /Uganda in October 2018.
From 16-20 April 2018, the fourth cohort of the GIBACHT programme (Global Partnership Initiated Academia for the Control of Health Threats) met for a workshop at the BNITM. This training is part of the German Biosecurity Programme, funded by the Federal Foreign Office and led by BNITM with the partner institutions Robert Koch Institute, Swiss Tropical and Public Health Institute, and the African Field Epidemiology Network. The goal of the programme is to strengthen national capacities in disaster management and the control of biological agents, and to foster international scientific exchange. After an introduction to the subject through e-learning modules in their home countries, the 15 participants from 11 countries got together for the first time in Hamburg and were further introduced to the topics biosafety, biosecurity and case study development. The next meeting will take place during a second workshop in Berlin in July 2018.
Our research fellow Oumou Maiga-Ascofaré was recently interviewed about her work and
her career path by the German Center for Infection Research (DZIF).
Here is the link to the full interview:
The second GIBACHT-cohort completed the Global Partnership Initiated Biosecurity Academia for Controlling Health Threats (GIBACHT) fellowship, a course series including computer learning activities and three on-campus workshops which were held in Hamburg and Berlin (Germany) and Kampala (Uganda).
Development and use of training material is a substantial part of the GIBACHT fellowship, thus making GIBACHT graduates multipliers who can train others in biosecurity and management of catastrophic health events. The final course of the second GIBACHT series took place in Kampala, organized by the African Field Epidemiology Network (AFENET). In the final workshop, GIBACHT fellows implemented their newly developed biosecurity and biosafety relevant case studies with students of the Makerere University (Kampala, Uganda)
The Infectious Disease Epidemiology working group at the BNITM starts a new project on "Genetic determinants for the transmission of Cryptosporidium spp. among humans and animals in Africa" in May 2016. The project will be funded by the German Research Foundation (DFG) within the "German-African collaborations in infectiology" Initiative. This program aims to investigate neglected infectious diseases in humans and animals as well as to establish research capacities in Africa and to build up inner- African research networks.
Cryptosporidium is a globally distributed single-celled organism that causes persistent diarrhea and malnutrition in immunocompetent individuals as well as severe diarrhea in immunosuppressed patients. Although Cryptosporidium is one of the most common pathogens causing diarrhea in children under the age of two in Africa, a substantial number of cases are thought to remain undiagnosed. The pathogen can be found in both humans and animals. However, there has been very little knowledge yet about the routes of transmission and the reservoirs in Africa. Treatment options have been insufficient.
The objective of this research project is to analyze the genetic diversity of African Cryptosporidium isolates by using whole genome sequencing methods in order to decode chains of transmission and to identify genetic determinants that affect the host specificity. The data will be important to introduce prevention measures and to find potential drug targets. The study will be conducted at four African research sites, in Gabon, Ghana, Madagascar and Tanzania, within a period of three years. The study will be accompanied by an extensive training program for young African scientists to establish a sustainable scientific network in East, West and Central Africa.